{"transactions":[{"id":2304761,"issuer":{"id":8459,"kind":"organization","name":"Valion Bio, Inc.","symbol":"VBIO"},"owners":[{"id":128313,"kind":"person","name":"Cai Veronica","position":1,"cik":"0001801322","reported_name":"Cai Veronica","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2022-04-05T17:15:04.000Z","date":"2022-04-01","kind":"grant","acquired":true,"shares":117880,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests as follows: (i) 25% one year from the grant date, and (ii) the remaining 75% in equal monthly installments over the 36 months thereafter."}],"balance_after":117880,"derivative":{"exercise_price":1.61,"expiration_date":"2032-03-31","underlying":"Common Stock","underlying_shares":117880},"source":{"system":"sec-edgar","filing":"0001104659-22-042855","document":"tm2211723d2_4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1801322/000110465922042855/tm2211723d2_4.xml","form_type":"4"}},{"id":3211455,"issuer":{"id":5247,"kind":"organization","name":"GYRE THERAPEUTICS, INC."},"owners":[{"id":128313,"kind":"person","name":"Cai Veronica","position":1,"cik":"0001801322","reported_name":"Cai Veronica","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Controller"}}],"security":"Common Stock","published_at":"2020-03-13T22:55:34.000Z","date":"2020-03-13","kind":"purchase","acquired":true,"shares":2000,"price":4.11,"value":8220.0,"ownership":{"direct":true},"balance_after":7353,"source":{"system":"sec-edgar","filing":"0001209191-20-019037","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1124105/000120919120019037/doc4.xml","form_type":"4"}},{"id":3277569,"issuer":{"id":5247,"kind":"organization","name":"GYRE THERAPEUTICS, INC."},"owners":[{"id":128313,"kind":"person","name":"Cai Veronica","position":1,"cik":"0001801322","reported_name":"Cai Veronica","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Controller"}}],"security":"Common Stock","published_at":"2020-02-13T01:27:49.000Z","date":"2020-02-10","kind":"grant","acquired":true,"shares":1678,"price":6.23,"value":10453.94,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Shares purchased under the Catalyst Biosciences, Inc. 2018 Employee Stock Purchase Plan (\"ESPP\") on February 10, 2020."}],"balance_after":5353,"source":{"system":"sec-edgar","filing":"0001209191-20-009039","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1124105/000120919120009039/doc4.xml","form_type":"4"}},{"id":3301462,"issuer":{"id":5247,"kind":"organization","name":"GYRE THERAPEUTICS, INC."},"owners":[{"id":128313,"kind":"person","name":"Cai Veronica","position":1,"cik":"0001801322","reported_name":"Cai Veronica","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Controller"}}],"security":"Stock Option (Right to Buy)","published_at":"2020-01-28T00:54:55.000Z","date":"2020-01-23","kind":"grant","acquired":true,"shares":12000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The grant vests monthly for four years from date of grant."}],"balance_after":12000,"derivative":{"exercise_price":6.85,"expiration_date":"2029-01-23","underlying":"Common Stock","underlying_shares":12000},"source":{"system":"sec-edgar","filing":"0001209191-20-005064","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1124105/000120919120005064/doc4.xml","form_type":"4"}},{"id":3301461,"issuer":{"id":5247,"kind":"organization","name":"GYRE THERAPEUTICS, INC."},"owners":[{"id":128313,"kind":"person","name":"Cai Veronica","position":1,"cik":"0001801322","reported_name":"Cai Veronica","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Controller"}}],"security":"Stock Option (Right to Buy)","published_at":"2020-01-28T00:54:19.000Z","date":"2019-09-16","kind":"grant","acquired":true,"shares":3000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Award vests over a four (4) year period on each monthly anniversary commencing September 3, 2019."}],"balance_after":3000,"derivative":{"exercise_price":6.22,"expiration_date":"2029-09-16","underlying":"Common Stock","underlying_shares":3000},"source":{"system":"sec-edgar","filing":"0001209191-20-005063","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1124105/000120919120005063/doc4.xml","form_type":"4"}}]}